AN
43
-6
TSCO
50
-3
AON
67
2
EIX
58
4
SCHW
58
2
ACN
52
-4
ETN
53
-2
DE
43
-3
EL
61
3
RSG
45
-3
SRE
44
2
DVA
47
-3
EOG
36
-9
GIS
60
3
SBUX
45
5
OMC
69
-3
JNJ
54
-3
FTI
58
-5
KMX
47
3
MDLZ
28
6
AN
43
-6
TSCO
50
-3
AON
67
2
EIX
58
4
SCHW
58
2
ACN
52
-4
ETN
53
-2
DE
43
-3
EL
61
3
RSG
45
-3
SRE
44
2
DVA
47
-3
EOG
36
-9
GIS
60
3
SBUX
45
5
OMC
69
-3
JNJ
54
-3
FTI
58
-5
KMX
47
3
MDLZ
28
6
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Insmed, Inc. Industry Stock Comparison

Buy
62

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.01
Seasonality Move:
0.94%
Sell
40

INSM
Insmed, Inc.

Last Price:
$174.52
Seasonality Move:
7.61%
Buy
62
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.02. The Score for JQC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy, Sell or Hold?

  • The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.02
    The current trend is relatively stagnant and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.

INSM Stock Price Chart

What is Insmed, Inc.'s stock price today?

  • The Insmed, Inc. share price today is $166.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.65 Sell
Chaikin Money Flow: 1323073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.99 - 5.09) Sell
Bollinger Bands (100): (5.05 - 5.45) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: -270452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.54 - 208.08) Sell
Bollinger Bands (100): (130.7 - 191.18) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.03 Sell
20-day SMA: 5.04 Sell
50-day SMA: 5.07 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.02 Sell
20-day EMA: 5.04 Sell
50-day EMA: 5.1 Sell
200-day EMA: 5.29 Sell

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.36 Sell
20-day SMA: 199.79 Sell
50-day SMA: 186.64 Sell
200-day SMA: 121.17 Buy
8-day EMA: 191.25 Sell
20-day EMA: 194.86 Sell
50-day EMA: 184.92 Sell
200-day EMA: 135.61 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed, Inc. Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):